Jasper Therapeutics, Inc. – NASDAQ:JSPR
Jasper Therapeutics stock price today
Jasper Therapeutics stock price monthly change
Jasper Therapeutics stock price quarterly change
Jasper Therapeutics stock price yearly change
Jasper Therapeutics key metrics
Market Cap | 315.02M |
Enterprise value | 18.30M |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | -0.36 |
Price/Sales | N/A |
Price/Book | 1.46 |
PEG ratio | N/A |
EPS | -5.60 |
Revenue | N/A |
EBITDA | -69.56M |
Income | -63.93M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeJasper Therapeutics stock price history
Jasper Therapeutics stock forecast
Jasper Therapeutics financial statements
$63
Potential upside: 2134.04%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 0 | -16.08M | |
|---|---|---|---|
| Sep 2023 | 0 | -17.54M | |
| Dec 2023 | 2.05M | -16.58M | -808.04% |
| Mar 2024 | 0 | -13.72M |
| 2024-02-13 | -1.61 | -1.5 |
|---|
| Jun 2023 | 124170000 | 13.96M | 11.25% |
|---|---|---|---|
| Sep 2023 | 110405000 | 16.27M | 14.74% |
| Dec 2023 | 95380000 | 14.67M | 15.39% |
| Mar 2024 | 125963000 | 10.46M | 8.31% |
| Jun 2023 | -13.27M | -11K | -305K |
|---|---|---|---|
| Sep 2023 | -11.98M | 0 | 36K |
| Dec 2023 | -16.47M | -230K | -271K |
| Mar 2024 | -15.73M | -25K | 47.34M |
Jasper Therapeutics alternative data
| Aug 2023 | 35 |
|---|---|
| Sep 2023 | 35 |
| Oct 2023 | 35 |
| Nov 2023 | 35 |
| Dec 2023 | 35 |
| Jan 2024 | 35 |
| Feb 2024 | 35 |
| Mar 2024 | 45 |
| Apr 2024 | 45 |
| May 2024 | 45 |
| Jun 2024 | 45 |
| Jul 2024 | 45 |
Jasper Therapeutics other data
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 540000 | 0 |
| Mar 2024 | 0 | 900 |
| Jun 2024 | 0 | 900 |
| Sep 2024 | 0 | 900 |
| Dec 2024 | 0 | 900 |
-
What's the price of Jasper Therapeutics stock today?
One share of Jasper Therapeutics stock can currently be purchased for approximately $2.82.
-
When is Jasper Therapeutics's next earnings date?
Unfortunately, Jasper Therapeutics's (JSPR) next earnings date is currently unknown.
-
Does Jasper Therapeutics pay dividends?
No, Jasper Therapeutics does not pay dividends.
-
How much money does Jasper Therapeutics make?
Jasper Therapeutics has a market capitalization of 315.02M. Jasper Therapeutics made a loss 64.47M US dollars in net income (profit) last year or -$1.5 on an earnings per share basis.
-
What is Jasper Therapeutics's stock symbol?
Jasper Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "JSPR".
-
What is Jasper Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Jasper Therapeutics?
Shares of Jasper Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Jasper Therapeutics have?
As Jul 2024, Jasper Therapeutics employs 45 workers.
-
When Jasper Therapeutics went public?
Jasper Therapeutics, Inc. is publicly traded company for more then 5 years since IPO on 10 Jan 2020.
-
What is Jasper Therapeutics's official website?
The official website for Jasper Therapeutics is jaspertherapeutics.com.
-
Where are Jasper Therapeutics's headquarters?
Jasper Therapeutics is headquartered at 2200 Bridge Pkwy, Redwood City, CA.
-
How can i contact Jasper Therapeutics?
Jasper Therapeutics's mailing address is 2200 Bridge Pkwy, Redwood City, CA and company can be reached via phone at +65 05491400.
-
What is Jasper Therapeutics stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Jasper Therapeutics in the last 12 months, the avarage price target is $63. The average price target represents a 2134.04% change from the last price of $2.82.
Jasper Therapeutics company profile:
Jasper Therapeutics, Inc.
jaspertherapeutics.comNASDAQ
45
Biotechnology
Healthcare
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
Redwood City, CA 94065
CIK: 0001788028
ISIN: US4718712023
CUSIP: 471871103
